Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 121Breast Neoplasms 83Colorectal Neoplasms 52Stomach Neoplasms 42Pancreatic Neoplasms 42Lung Neoplasms 41Rectal Neoplasms 38Neoplasm Metastasis 36Neoplasms 33Esophageal Squamous Cell Carcinoma 32Esophageal Neoplasms 31Head and Neck Neoplasms 26Squamous Cell Carcinoma of Head and Neck 23Ovarian Neoplasms 23Triple Negative Breast Neoplasms 21Nasopharyngeal Carcinoma 20Recurrence 18Leukemia, Myeloid, Acute 18Colonic Neoplasms 18Uterine Cervical Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Small Cell Lung Carcinoma 15Glioblastoma 15Lymphoma 12Prostatic Neoplasms 11Fallopian Tube Neoplasms 11Carcinoma, Squamous Cell 11Brain Neoplasms 11Sarcoma 10NSCLC 9

Interventions

Etoposide 3Drug Therapy 2Cisplatin 2toripalimab 1apatinib 1anlotinib 1Radiation Dose Hypofractionation 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Small Cell Lung Cancer Limited Stage × Drug Therapy × Clear all
NCT05651802 2023-12-19

PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients

Zhejiang Cancer Hospital

Phase NA Recruiting
220 enrolled
Thoracic

Small Cell Lung Cancer Limited Stage

NCT03214003 2023-06-22

TRISS

Peking University Cancer Hospital & Institute

Phase NA Completed
235 enrolled
Thoracic

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡